TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19961025

Group type: EXPERIMENTAL
Intervention: Humidified CPAP
Number of subjects: 125

Group type: COMPARATOR
Intervention: Dry CPAP
Number of subjects: 125

Group type: COMPARATOR
Intervention: CPAP with fluticasone
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: All groups (dry, fluticasone, humidifier)
Number of subjects: 125
Study: 16982235

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 microg)
Number of subjects: 1424

Group type: COMPARATOR
Intervention: Vaginal misoprostol (400 microg)
Number of subjects: 1424
Study: 15569335

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (2 g/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 10767752

Group type: EXPERIMENTAL
Intervention: Patient-centred consulting style
Number of subjects: 161

Group type: COMPARATOR
Intervention: Doctor-centred consulting style
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Watching a poor prognosis video
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Being employed in a professional occupation
Number of subjects: 161
Study: 9306037

Group type: EXPERIMENTAL
Intervention: 100 g of oral glucose
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 1 mg of intravenous glucagon
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Insulin treatment for 10-14 days in 15 poorly controlled NIDDM patients
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 46
Study: 8371179

Group type: EXPERIMENTAL
Intervention: Intraoral appliances (IA)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Biofeedback and stress management (BF/SM)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Combination of IA and BF/SM
Number of subjects: 110

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 110
Study: 3723621

Group type: EXPERIMENTAL
Intervention: Antishock trousers inflated to 50 mm Hg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Antishock trousers inflated to 100 mm Hg
Number of subjects: 8
Study: 29189045

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 80
Study: 27671178

Group type: EXPERIMENTAL
Intervention: Conventional methacrylate based composite using incremental technique (Group A, n=40)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Low stress methacrylate resin based composite SDR using single step technique (Group B, n=40)
Number of subjects: 120
Study: 24719474

Group type: EXPERIMENTAL
Intervention: Ad5HVR48.EnvA.01 vaccine (10^9 to 10^11 viral particles)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 22699098

Group type: EXPERIMENTAL
Intervention: Supported Speed Treadmill Training Exercise Program (SSTTEP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Strengthening exercise program
Number of subjects: 26
Study: 20207324

Group type: EXPERIMENTAL
Intervention: Music intervention group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Quiet rest group
Number of subjects: 56
Study: 18754438

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1.00 mg/kg (0.15%-0.20%)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1.25 mg/kg (0.20%-0.25%)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1.50 mg/kg (0.30%-0.35%)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ropivacaine 2.00 mg/kg (0.30%-0.35%)
Number of subjects: 200
Study: 16483488

Group type: EXPERIMENTAL
Intervention: Oxaliplatin plus vinorelbine (NL group)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Cisplatin plus vinorelbine (NP group)
Number of subjects: 102
Study: 12592683

Group type: EXPERIMENTAL
Intervention: Combined treated group (CWT + DSQ)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional western therapy (CWT)
Number of subjects: 64
Study: 10379638

Group type: COMPARATOR
Intervention: Clozapine 12.5 mg alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clozapine 12.5 mg with erythromycin 1500 mg
Number of subjects: 12
Study: 9295496

Group type: EXPERIMENTAL
Intervention: Modified element diet (dextrin as glycogen) via nasal feeding tube
Number of subjects: 20

Group type: COMPARATOR
Intervention: Common nutritional support method
Number of subjects: 20
Study: 1870835

Group type: EXPERIMENTAL
Intervention: Doxium (calcium dobesilate) 500 mg, 3 capsules daily for 6 months
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo, 3 capsules daily for 6 months
Number of subjects: 79
Study: 7038483

Group type: EXPERIMENTAL
Intervention: Oral digoxin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31269891

Group type: EXPERIMENTAL
Intervention: Micronized palmitoylethanolamide 600 mg/die
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28334632

Group type: EXPERIMENTAL
Intervention: Average sleep duration at 4th grade
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhibitory control at 5th grade
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekend bed-time delay at 4th grade
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekend wake-time delay at 4th grade
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reductions in nightly sleep
Number of subjects: 0
Study: 25827448

Group type: EXPERIMENTAL
Intervention: Terminalia arjuna (500 mg twice a day)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 23063141

Group type: EXPERIMENTAL
Intervention: Ivabradine 7.5mg
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Ivabradine 5mg
Number of subjects: 259

Group type: COMPARATOR
Intervention: Beta-blocker therapy (continued without modification)
Number of subjects: 259
Study: 21564523

Group type: EXPERIMENTAL
Intervention: Sotrastaurin (300 mg b.i.d.)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Tacrolimus (control)
Number of subjects: 125
Study: 18356022

Group type: EXPERIMENTAL
Intervention: Hard splints
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Soft splints
Number of subjects: 45

Group type: COMPARATOR
Intervention: No splint (Control)
Number of subjects: 45
Study: 16849748

Group type: COMPARATOR
Intervention: rIFL (reduced-dose bolus fluorouracil plus leucovorin and irinotecan)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: FOLFOX4 (infused fluorouracil plus leucovorin and oxaliplatin)
Number of subjects: 305

Group type: COMPARATOR
Intervention: rIFL
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: FOLFOX4
Number of subjects: 305

Group type: COMPARATOR
Intervention: rIFL and FOLFOX4
Number of subjects: 305
Study: 12170038

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.125% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rescue dextropropoxyphene tablets
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Overall satisfaction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Local anesthetic toxicity or catheter infection
Number of subjects: 60
Study: 10446825

Group type: EXPERIMENTAL
Intervention: TNF-alpha (1.25, 12.5, 125, or 250 pg/mL for 20 mins)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-1beta (6.25, 12.5, 50, or 200 pg/mL for 20 mins)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TNF-alpha (1.25 pg/mL) plus IL-1beta (6.25 pg/mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceramidase inhibitor N-oleoyl ethanolamine (1 microM) or NO synthase inhibitor N(G)-monomethyl-L-arginine (10 microM)
Number of subjects: 0
Study: 7597397

Group type: EXPERIMENTAL
Intervention: Textured expander prostheses
Number of subjects: 20

Group type: COMPARATOR
Intervention: Smooth expander prostheses
Number of subjects: 20
Study: 2085967

Group type: EXPERIMENTAL
Intervention: TCu 380A (ParaGard)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparative devices (Lippes Loop D, TCu 200, TCu 220, Multiload Cu 250)
Number of subjects: 0
Study: 313765

Group type: EXPERIMENTAL
Intervention: Group 2 (n = 120) received a bolus of hypertonic glucose, insulin, and potassium in the pump perfusate before aortic cross‐clamping.
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Group 3 (n = 114) had the aortic root continuously infused with glucose, insulin, and potassium solution at 4 degrees C during aortic cross‐clamping.
Number of subjects: 391

Group type: COMPARATOR
Intervention: Control Group 1 (n = 157) received no additional glucose, insulin, and potassium solutions.
Number of subjects: 391
Study: 7045433

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 31237191

Group type: EXPERIMENTAL
Intervention: 600 mg CBD
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 29386049

Group type: EXPERIMENTAL
Intervention: Intrathecal administration of autologous bone marrow mononuclear cells and standard neurorehabilitation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard neurorehabilitation
Number of subjects: 58
Study: 26809243

Group type: EXPERIMENTAL
Intervention: Epigallocatechin-gallate (EGCG) supplementation for 48 weeks
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 24574125

Group type: EXPERIMENTAL
Intervention: Budesonide (0.25 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22356215

Group type: EXPERIMENTAL
Intervention: Controlled-release (CR) orally disintegrating tablets (ODT) and CR capsules (50 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate-release (IR) syrup (reference)
Number of subjects: 0
Study: 21044101

Group type: EXPERIMENTAL
Intervention: n-3 supplement (TheraTears Nutrition®)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wheat germ oil
Number of subjects: 61
Study: 17568957

Group type: EXPERIMENTAL
Intervention: Tailored text messages delivered via handheld computers
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group using handheld computers for daily surveys
Number of subjects: 40
Study: 15930540

Group type: EXPERIMENTAL
Intervention: Low-dose shock wave therapy without anesthetic
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Crossover patients receiving active treatment after placebo
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Functional activity scores and overall impression of disease state
Number of subjects: 114
Study: 11845223

Group type: EXPERIMENTAL
Intervention: Prednisolone (30 mg/day for 6 days)
Number of subjects: 8
Study: 10417465

Group type: EXPERIMENTAL
Intervention: Oxygen insufflation at a constant flow of 21.min‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 1: Ophthalmic drape A
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 2: Ophthalmic drape B
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 3: Ophthalmic drape C
Number of subjects: 60
Study: 7573241

Group type: EXPERIMENTAL
Intervention: Laparoscopic excision
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 40
Study: 2205624

Group type: EXPERIMENTAL
Intervention: Continuous combined estrogen/progestogen therapy (2 mg estradiol + 1 mg norethisterone acetate + 500 mg calcium daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo + 500 mg calcium daily
Number of subjects: 40
Study: 6992626

Group type: EXPERIMENTAL
Intervention: 5 mg oral terbutaline
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 2.5 mg terbutaline t.i.d. for a week
Number of subjects: 8
Study: 31231863

Group type: EXPERIMENTAL
Intervention: Caseload midwifery
Number of subjects: 1748

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1748
Study: 27137171

Group type: EXPERIMENTAL
Intervention: Full-Can (FC)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Empty-Can (EC)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Prone Horizontal Abduction (PHA)
Number of subjects: 34
Study: 28194194

Group type: EXPERIMENTAL
Intervention: Islam-based religious program (8 sessions)
Number of subjects: 52
Study: 24386900

Group type: EXPERIMENTAL
Intervention: Twice-weekly, physiotherapist-led exercise classes
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Training for care home staff
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Exercise groups
Number of subjects: 1000
Study: 21593280

Group type: EXPERIMENTAL
Intervention: 10 mg ilaprazole once daily for 7 days
Number of subjects: 27
Study: 19942720

Group type: EXPERIMENTAL
Intervention: Intramuscular electrical stimulation at latent MTrPs
Number of subjects: 13

Group type: COMPARATOR
Intervention: Electrical stimulation of tibial nerve
Number of subjects: 13
Study: 17457161

Group type: EXPERIMENTAL
Intervention: Binding pancreaticojejunostomy
Number of subjects: 217

Group type: COMPARATOR
Intervention: Conventional pancreaticojejunostomy
Number of subjects: 217
Study: 14744832

Group type: EXPERIMENTAL
Intervention: Bisphosphonate therapy
Number of subjects: 0
Study: 12067876

Group type: EXPERIMENTAL
Intervention: Cricoid pressure
Number of subjects: 33

Group type: COMPARATOR
Intervention: No cricoid pressure
Number of subjects: 33
Study: 9797593

Group type: EXPERIMENTAL
Intervention: EMG biofeedback training and conventional medical treatment (BFT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional medical treatment alone (Control)
Number of subjects: 29
Study: 9346036

Group type: EXPERIMENTAL
Intervention: 12 week water safety and swimming lessons
Number of subjects: 109

Group type: COMPARATOR
Intervention: 8 week water safety and swimming lessons
Number of subjects: 109
Study: 2694330

Group type: EXPERIMENTAL
Intervention: Pirenzepine treatment for 4 weeks
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 128
Study: 848514

Group type: EXPERIMENTAL
Intervention: Same-categories transfer condition
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: New-categories group
Number of subjects: 72

Group type: COMPARATOR
Intervention: Random and blocked format lists
Number of subjects: 72
Study: 31968301

Group type: EXPERIMENTAL
Intervention: Within-treatment frequency of use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Within-treatment abstinence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-report of days of use
Number of subjects: 0
Study: 30575054

Group type: COMPARATOR
Intervention: No antibiotic (Group A)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Intravenous (IV) antibiotic for 1 day (Group B)
Number of subjects: 450

Group type: COMPARATOR
Intervention: 1 day IV plus 7 days oral antibiotic (Group C)
Number of subjects: 450
Study: 28421639

Group type: EXPERIMENTAL
Intervention: cilostazol (50 mg twice a day)
Number of subjects: 84

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 84
Study: 26537207

Group type: EXPERIMENTAL
Intervention: Secondary sentinel lymph node (SSLN) tracing technique with Methylthioninium chloride injection in group A (138 patients)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Standard D2 radical gastrectomy in group B (109 patients)
Number of subjects: 247
Study: 23789213

Group type: EXPERIMENTAL
Intervention: Dingqi analgesic patch
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham patch (Control)
Number of subjects: 40
Study: 21653207

Group type: EXPERIMENTAL
Intervention: Short mesial resection (2.5 cm, n=34)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Long mesial resection (3.5 cm, n=33)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Resected hippocampal volume (larger left hippocampal volumes)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Resected hippocampal volume (larger volumes on either side)
Number of subjects: 67
Study: 18089661

Group type: EXPERIMENTAL
Intervention: Motivation programme provided by a trained clinical psychologist (n=70)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care (n=70)
Number of subjects: 140
Study: 17179643

Group type: EXPERIMENTAL
Intervention: Education program for supervisors (24 supervisors), single-session, 60-min duration.
Number of subjects: 301

Group type: COMPARATOR
Intervention: Waiting-list group (22 supervisors), no education program.
Number of subjects: 301
Study: 14525823

Group type: EXPERIMENTAL
Intervention: Lightwand intubation (n = 41)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Direct-vision laryngoscopy (n = 39)
Number of subjects: 80
Study: 11097156

Group type: EXPERIMENTAL
Intervention: Antisense oligodeoxynucleotides at 200, 400, and 800 micromol/L
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sense oligodeoxynucleotides at 100, 200, 400, and 800 micromol/L
Number of subjects: 10
Study: 8651671

Group type: EXPERIMENTAL
Intervention: Continuously warmed i.v. fluids (37.0 degrees C)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Prewarmed i.v. fluids that cooled to room temperature
Number of subjects: 2
Study: 1352049

Group type: EXPERIMENTAL
Intervention: Schizophrenia diagnostic classification
Number of subjects: 326

Group type: COMPARATOR
Intervention: Other diagnostic classifications
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Psychological test performance
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Concurrent mental state abnormalities
Number of subjects: 326
Study: 6730937

Group type: EXPERIMENTAL
Intervention: Spontaneous delivery
Number of subjects: 46

Group type: COMPARATOR
Intervention: Forceps delivery
Number of subjects: 46
Study: 29853559

Group type: EXPERIMENTAL
Intervention: Menthol cigarette ban compliance
Number of subjects: 90

Group type: COMPARATOR
Intervention: Gas stations
Number of subjects: 90
Study: 30512083

Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed arthroscopic partial meniscectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 0
Study: 27217310

Group type: EXPERIMENTAL
Intervention: SPF implementation in intervention group
Number of subjects: 25

Group type: COMPARATOR
Intervention: Matched comparison group
Number of subjects: 25
Study: 26678391

Group type: EXPERIMENTAL
Intervention: Pharmacological REM sleep deprivation (clonidine)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Inert control pill
Number of subjects: 26
Study: 23240877

Group type: EXPERIMENTAL
Intervention: NovaMin(®) paste (NM) followed by Nd:YAG laser irradiation at 1W (group B)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser irradiation at 1W (group G)
Number of subjects: 49

Group type: COMPARATOR
Intervention: NovaMin(®) paste (NM)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Nd:YAG laser irradiation at 0.5W (group A)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Nd:YAG laser irradiation at 0.5W (group C)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Nd:YAG laser irradiation at 1W (group D)
Number of subjects: 49

Group type: COMPARATOR
Intervention: NovaMin(®) paste (NM) (group E)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Nd:YAG laser irradiation at 0.5W (group F)
Number of subjects: 49
Study: 21501001

Group type: EXPERIMENTAL
Intervention: Oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate
Number of subjects: 66
Study: 18436116

Group type: EXPERIMENTAL
Intervention: Bivalirudin monotherapy
Number of subjects: 3852

Group type: EXPERIMENTAL
Intervention: Bivalirudin plus GPI
Number of subjects: 3852

Group type: COMPARATOR
Intervention: Heparin plus GPI
Number of subjects: 3852
Study: 16470361

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14675269

Group type: EXPERIMENTAL
Intervention: Omeprazole treatment for 4 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (dyspepsia-free controls)
Number of subjects: 19
Study: 10789600

Group type: EXPERIMENTAL
Intervention: Pulse pressure
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Mean pressure
Number of subjects: 840
Study: 9366737

Group type: EXPERIMENTAL
Intervention: Home exercise programme of strength and balance retraining exercises
Number of subjects: 233

Group type: COMPARATOR
Intervention: Usual care and social visits (control group)
Number of subjects: 233
Study: 7877128

Group type: EXPERIMENTAL
Intervention: Cognitive psychotherapy (10 sessions of 50 min duration)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 100
Study: 3170995

Group type: EXPERIMENTAL
Intervention: Immunotherapy (IT) with birch extract
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no IT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 30648520

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 32
Study: 28921523

Group type: EXPERIMENTAL
Intervention: Growth mindset intervention (30-min, computer-guided)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Supportive-therapy control
Number of subjects: 96
Study: 26895983

Group type: EXPERIMENTAL
Intervention: Education plus contact (interactive session with a young person with lived experience of mental illness)
Number of subjects: 769

Group type: COMPARATOR
Intervention: Education alone (1-day educational programme led by mental health professional staff)
Number of subjects: 769
Study: 25809095

Group type: EXPERIMENTAL
Intervention: Pressure ulcer (PU) prevention bundle
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard skin care as per local ICU policies (Control)
Number of subjects: 140
Study: 22520085

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 20100966

Group type: EXPERIMENTAL
Intervention: cetuximab/TC
Number of subjects: 676

Group type: COMPARATOR
Intervention: TC
Number of subjects: 676
Study: 18842777

Group type: EXPERIMENTAL
Intervention: Whole almond seed macroparticles (WA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Almond oil (AO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sunflower oil blend (CO)
Number of subjects: 20